Recent approvals – do they make a difference? Access Viewpoint here: Recent approvals – do they make a difference? – by Ursula Theuretzbacher Author: Ursula Theuretzbacher Tags: Antimicrobial Viewpoint article, Phase 3, Regulatory, IAI, UTI, Gram negative, WHO priority pathogens, Aminoglycosides
